
Sagar S. Patel
Examiner (ID: 15778, Phone: (571)272-1317 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 657 |
| Issued Applications | 436 |
| Pending Applications | 84 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18647757
[patent_doc_number] => 20230293528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 17/975939
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975939 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Oct 27, 2022 | Issued |
Array
(
[id] => 18323920
[patent_doc_number] => 20230122048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS
[patent_app_type] => utility
[patent_app_number] => 17/973714
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/973714 | Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumours | Oct 25, 2022 | Issued |
Array
(
[id] => 18282617
[patent_doc_number] => 20230098089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL ACTIVE DERIVATIVE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/047454
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047454 | Multi-arm single molecular weight polyethylene glycol active derivative and application thereof | Oct 17, 2022 | Issued |
Array
(
[id] => 19629651
[patent_doc_number] => 20240408100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => TREATMENT METHODS FOR SUBJECTS HAVING CANCER WITH A DYSREGULATED MAPK AND/OR PI3K PATHWAY
[patent_app_type] => utility
[patent_app_number] => 18/699669
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18699669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/699669 | TREATMENT METHODS FOR SUBJECTS HAVING CANCER WITH A DYSREGULATED MAPK AND/OR PI3K PATHWAY | Oct 12, 2022 | Pending |
Array
(
[id] => 19613073
[patent_doc_number] => 20240398753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/699647
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18699647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/699647 | METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION | Oct 10, 2022 | Pending |
Array
(
[id] => 19556318
[patent_doc_number] => 20240368110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => PROCESS FOR PURIFYING MESO-LACTIDE
[patent_app_type] => utility
[patent_app_number] => 18/689533
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18689533
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/689533 | PROCESS FOR PURIFYING MESO-LACTIDE | Sep 8, 2022 | Pending |
Array
(
[id] => 20143906
[patent_doc_number] => 12378233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Immunomodulating azalides
[patent_app_type] => utility
[patent_app_number] => 17/929777
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 58668
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 554
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929777 | Immunomodulating azalides | Sep 5, 2022 | Issued |
Array
(
[id] => 18522907
[patent_doc_number] => 20230233557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/930015
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930015 | FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS | Sep 5, 2022 | Abandoned |
Array
(
[id] => 19584889
[patent_doc_number] => 20240382446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => METHOD FOR IMPROVING FEED INTAKE
[patent_app_type] => utility
[patent_app_number] => 18/686681
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18686681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/686681 | METHOD FOR IMPROVING FEED INTAKE | Aug 31, 2022 | Pending |
Array
(
[id] => 19430888
[patent_doc_number] => 20240299386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/571331
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571331 | Novel imidazole derivatives having protein kinase inhibitory activity and uses thereof | Aug 15, 2022 | Pending |
Array
(
[id] => 20254867
[patent_doc_number] => 12427200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Compositions and methods for the treatment of viral infections
[patent_app_type] => utility
[patent_app_number] => 17/887776
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 149
[patent_figures_cnt] => 216
[patent_no_of_words] => 178391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/887776 | Compositions and methods for the treatment of viral infections | Aug 14, 2022 | Issued |
Array
(
[id] => 19528087
[patent_doc_number] => 20240351989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/682361
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682361
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682361 | PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF | Aug 7, 2022 | Pending |
Array
(
[id] => 18344901
[patent_doc_number] => 20230133011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES
[patent_app_type] => utility
[patent_app_number] => 17/816980
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816980 | MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES | Aug 1, 2022 | Pending |
Array
(
[id] => 18036131
[patent_doc_number] => 20220380346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => 2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 17/871458
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871458 | 2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Jul 21, 2022 | Abandoned |
Array
(
[id] => 18830781
[patent_doc_number] => 20230399305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PROCESS FOR PREPARING HIGH-DENSITY QUERCETIN
[patent_app_type] => utility
[patent_app_number] => 17/859656
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/859656 | Process for preparing high-density quercetin | Jul 6, 2022 | Issued |
Array
(
[id] => 18298439
[patent_doc_number] => 20230108125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => SMALL MOLECULE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/849600
[patent_app_country] => US
[patent_app_date] => 2022-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 592
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849600 | SMALL MOLECULE COMPOUNDS | Jun 24, 2022 | Abandoned |
Array
(
[id] => 18309136
[patent_doc_number] => 20230113036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 17/807245
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17807245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/807245 | Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance | Jun 15, 2022 | Issued |
Array
(
[id] => 17929747
[patent_doc_number] => 20220324872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => CDK2/4/6 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/841138
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/841138 | CDK2/4/6 Inhibitors | Jun 14, 2022 | Abandoned |
Array
(
[id] => 18698607
[patent_doc_number] => 20230329090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SPIRO COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/020916
[patent_app_country] => US
[patent_app_date] => 2022-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020916 | SPIRO COMPOUND AND APPLICATION THEREOF | Jun 10, 2022 | Pending |
Array
(
[id] => 20715264
[patent_doc_number] => 12630498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-19
[patent_title] => Arylamides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/832384
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30062
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832384 | Arylamides and methods of use thereof | Jun 2, 2022 | Issued |